Familial Adenomatous Polyposis
What's New
Last Posted: May 30, 2024
- Progression of nodular thyroid disease in Familial Adenomatous Polyposis syndrome: refined surveillance recommendations.
Gustavo Romero-Velez et al. Endocr Pract 2024 - IMPACT OF ENDOSCOPIC TREATMENT IN SEVERE DUODENAL POLYPOSIS: A NATIONAL STUDY IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS.
Pierrine Le Bras et al. Clin Gastroenterol Hepatol 2024 - Surveillance Compliance and Quality of Life Assessment Among Surgical Patients with Familial Adenomatous Polyposis Syndrome.
Noura Alhassan et al. J Epidemiol Glob Health 2024 - Secondary (additional) findings from the 100,000 Genomes Project: disease manifestation, healthcare outcomes and costs of disclosure.
Joshua Nolan et al. Genet Med 2023 101051 - Risk of Proctectomy After Ileorectal Anastomosis in Familial Adenomatous Polyposis in the Modern Era.
Sudeep Banerjee et al. Dis Colon Rectum 2023 - Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer.
Jennifer Thalita Targino Dos Santos et al. Genes (Basel) 2023 14(11) - Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer.
Hareem Syed et al. J Natl Compr Canc Netw 2023 21(11) 1156-1163.e5 - Cost-effectiveness of preventive aspirin use and intensive downstaging polypectomy in patients with familial adenomatous polyposis: A microsimulation modeling study.
Eiko Saito et al. Cancer Med 2023 - Low adenoma burden in unselected patients with a pathogenic APC variant.
Rachel Schwiter et al. Genet Med 2023 100949 - The Cumulative Incidence and Progression of Ileal Pouch Adenomas in Patients with Familial Adenomatous Polyposis.
Chun Hin Angus Lee et al. Dis Colon Rectum 2023
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: